The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Phase 1/2 study of veliparib (V) combined with carboplatin (Cb) and etoposide (E) in patients (pts) with extensive-stage disease (ED) small cell lung cancer (SCLC) and other solid tumors: Phase 1 results.
 
Florence Atrafi
No Relationships to Disclose
 
Harry J.M. Groen
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Lilly (Inst); Roche (Inst)
 
Lauren Averett Byers
Consulting or Advisory Role - Abbvie; AstraZeneca; Biomarin; Medivation
Research Funding - Takeda
 
Elena Garralda
No Relationships to Disclose
 
Martijn P. Lolkema
Consulting or Advisory Role - Amgen; ERYTECH Pharma; Johnson & Johnson
Research Funding - Astellas Pharma (Inst); Johnson & Johnson (Inst); Sanofi (Inst)
 
Randeep S. Sangha
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Lundbeck; Merck; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Lundbeck; Merck; Roche
Research Funding - Abbvie (Inst); Agensys (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst)
 
Santiago Viteri Ramirez
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Idea Pharma; Novartis; Promega; Roche; Targovax
Research Funding - Abbvie; ARIAD; Astex Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; CytRx Corporation; Daiichi Sankyo; GlaxoSmithKline; Hanmi; Incyte; MedImmune; Merck KGaA; Novartis; Pfizer; Puma Biotechnology; Roche; SERVIER
 
Young Kwang Chae
Speakers' Bureau - merck
Travel, Accommodations, Expenses - Hanmi; MedImmune
 
D. Ross Camidge
No Relationships to Disclose
 
Nashat Y. Gabrail
No Relationships to Disclose
 
Tina Waskiewicz
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Beibei Hu
No Relationships to Disclose
 
Tu Xu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Silpa Nuthalapati
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Elizabeth Hoening
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Philip Komarnitsky
Employment - Abbvie; AVEO; Sanofi (I)
Stock and Other Ownership Interests - Abbvie; AVEO; Sanofi (I)
Patents, Royalties, Other Intellectual Property - AVEO
 
Antonio Calles Blanco
No Relationships to Disclose